Cardiovascular Journal of Africa: Vol 27 No 2 (March/April 2016)

29 / 72

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 2, March/April 2016 AFRICA 83
sus on preconception care to reduce maternal and childhood mortality and
morbidity, 2012.
3. Elsinga J, de Jong-Potjer LC, van der Pal-de Bruin KM, le Cessie S,
Assendelft WJ, Buitendijk SE. The effect of preconception counselling on
lifestyle and other behaviour before and during pregnancy. Womens Health
Issues 2008; 18: S117–25.
4. Elsinga J, van der Pal-de Bruin K, le Cessie S, de Jong-Potjer L, Verloove-
Vanhorick S, Assendelft W. Preconception counselling initiated by general
practitioners in the Netherlands: reaching couples contemplating preg-
nancy [ISRCTN53942912]. BMC Fam Pract 2006; 7: 41.
5. Simpson LL. Preconception considerations. Seminars Perinatol 2014; 38:
236–239.
6. Simpson LL. Preconception considerations. Seminars Perinatol 2014; 38:
236–239.
7. Williams RG. Increased survival of congenital heart disease: how did we get
here and now what? J Am Coll Cardiol 2015; 66: 45–46.
8. Zuhlke L, Mirabel M, Marijon E. Congenital heart disease and rheumatic
heart disease in Africa: recent advances and current priorities. Heart 2013;
99: 1554–1561.
9. Mocumbi AO. The challenges of cardiac surgery for African children.
Cardiovasc J Afr 2012; 23: 165–167.
10. Gandhi M, Martin SR. Cardiac disease in pregnancy. Obstet Gynecol Clin
North Am 2015; 42: 315–333.
11. Sliwa K, Libhaber E, Elliott C, Momberg Z, Osman A, Zühlke L, et al.
Spectrum of cardiac disease in maternity in a low-resource cohort in South
Africa. Heart 2014; 100: 1967–1974.
12. Thorne SA. Pregnancy in heart disease. Heart 2004; 90: 450–456.
13. Bedard E, Dimopoulos K, Gatzoulis MA. Has there been any progress
made on pregnancy outcomes among women with pulmonary arterial
hypertension? Eur Heart J 2009; 30: 256–265.
14. Brown ML, Burkhart HM, Connolly HM, Dearani JA, Cetta F, Li Z, et
al. Coarctation of the aorta: lifelong surveillance is mandatory following
surgical repair. J Am Coll Cardiol 2013; 62: 1020–1025.
15. Vriend JW, Mulder BJ. Late complications in patients after repair of aortic
coarctation: implications for management. Int J Cardiol 2005; 101: 399–406.
16. Walker E, Malins AF. Anaesthetic management of aortic coarctation in
pregnancy. Int J Obstet Anesth 2004; 13: 266–270.
17. Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S.
Incidence and characteristics of newly diagnosed rheumatic heart disease
in urban African adults: insights from the heart of Soweto study. Eur Heart
J 2010; 31: 719–727.
18. Engel ME, Haileamlak A, Zühlke L, Lemmer CE, Nkepu S, Wall MVD,
et al. Latent rheumatic heart disease in 4720 asymptomatic schoolchildren
from South Africa and Ethiopia. Heart 2015; 101: 1389–1394.
19. Beaton A, Okello E, Lwabi P, Mondo C, McCarter R, Sable C.
Echocardiography screening for rheumatic heart disease in Ugandan
schoolchildren. Circulation 2012; 125 : 3127–3132.
20. Zühlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P, Cupido B,
et al. Characteristics, complications, and gaps in evidence-based interven-
tions in rheumatic heart disease: the Global Rheumatic Heart Disease
Registry (the REMEDY study). Eur Heart J 2015; 36: 1115–1122.
21. Zhang W, Mondo C, Okello E, Musoke C, Kakande B, Nyakoojo W, et al.
Presenting features of newly diagnosed rheumatic heart disease patients in
Mulago Hospital: A pilot study. Cardiovasc J Afr 2013; 24: 28–33.
22. Dennis A. Valvular heart disease in pregnancy. Int J Obstet Anesth 2016;
25: 4–8.
23. Windram JD, Colman JM, Wald RM, Udell JA, Siu SC, Silversides CK.
Valvular heart disease in pregnancy. Best Pract Res Clin Obstet Gynaecol
2014; 28: 507–518.
24. Diao M, Kane A, Ndiaye MB, Mbaye A, Bodian M, Dia MM, et al.
Pregnancy in women with heart disease in sub-Saharan Africa. Arch
Cardiovasc Dis 2011; 104: 370–374.
25. Senaratne V. Percutaneous interventions in stenotic valvular heart disease
complicating pregnancy. Ceylon Med J 2003; 48: 109–111.
26. Sliwa K, Johnson MR, Zilla P, Roos-Hesselink JW. Management of valvular
disease in pregnancy: a global perspective. Eur Heart J 2015; 36: 1078–1089.
27. Cardoso G, Aguiar C, Andrade MJ, Patricio L, Freire I, Serrano F, et al .
Prosthetic mitral valve thrombosis in pregnancy: from thrombolysis to
anticoagulation. Rev Port Cardiol 2015; 34: 71.e1–5.
28. Wang D, Liu M, Lin S, Hao Z, Tao W, Chen X, et al. Stroke and rheumatic
heart disease: a systematic review of observational studies. Clin Neurol
Neurosurg 2013; 115: 1575–1582.
29. Alwan S, Polifka JE, Friedman JM. Angiotensin II receptor antagonist
treatment during pregnancy. Birth Defects Res A Clin Mol Teratol 2005;
73: 123–130.
30. Lavoratti G, Seracini D, Fiorini P, Cocchi C, Materassi M, Donzelli G et
al . Neonatal anuria by ACE inhibitors during pregnancy. Nephron 1997;
76: 235–236.
31. Schubiger G, Flury G, Nussberger J. Enalapril for pregnancy-induced hyper-
tension: acute renal failure in a neonate. Ann Intern Med 1988;108 : 215–216.
32. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon
PS, et al. Major congenital malformations after first-trimester exposure to
ACE inhibitors. N Engl J Med 2006; 354: 2443–2451.
33. Bao L, Salomon JA, Brown T, Raftery AE, Hogan DR. Modelling national
HIV/AIDS epidemics: revised approach in the UNAIDS Estimation and
Projection Package 2011. Sex Transm Infect 2012; 88(Suppl 2): i3–10.
34. Joint United Nations Programme on HIV/AIDS (UNAIDS) 2013.
UNAIDS report of the Global AIDS epidemic. URL:
org/sites/default/files/media_asset/UNAIDS_Global_Report_2013_en_1.
pdf access date 31 March 2016.
35. Momplaisir FM, Brady KA, Fekete T, Thompson DR, Diez Roux A,
Yehia BR. Time of HIV diagnosis and engagement in prenatal care impact
virologic outcomes of pregnant women with HIV. PLoS One 2015; 10:
e0132262.
36. Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg
L, et al. Antiretroviral therapy adherence, virologic and immunologic
outcomes in adolescents compared with adults in southern Africa. J Acquir
Immune Defic Syndr 2009; 51: 65–71.
37. Matthews LT, Milford C, Kaida A, Ehrlich MJ, Ng C, Greener R, et al .
Lost opportunities to reduce periconception HIV transmission: safer
conception counseling by South African providers addresses perinatal but
not sexual HIV transmission. J Acquir Immune Defic Syndr 2014; 67(Suppl
4): S210–217.
38. Stanwood NL, Cohn SE, Heiser JR, Pugliese M. Contraception and fertil-
ity plans in a cohort of HIV-positive women in care. Contraception 2007;
75: 294–298.
39. Executive summary of the GESIDA/National AIDS Plan Consensus
Document on antiretroviral therapy in adults infected by the human immu-
nodeficiency virus (updated January 2015). Enferm Infec Microbiol Clin
2015; 33(8): 544–556. Epub 2015 May 26.
40. Prestes-Carneiro LE. Antiretroviral therapy, pregnancy, and birth defects:
a discussion on the updated data. HIV AIDS (Auckl) 2013; 5: 181–189.
41. World Health Organisation (Geneva). Antiretroviral drugs for treating
pregnant women and preventing HIV infection in infants, 2010 version.
URL:
eng.pdf access date 31 March 2016.
42. Nachega JB, Mutamba B, Basangwa D, Nguyen H, Dowdy DW, Mills EJ,
et al. Severe mental illness at ART initiation is associated with worse reten-
tion in care among HIV-infected Ugandan adults. Trop Med Int Health
2013; 18: 53–57.